Correction to Noncovalent Mutant Selective Epidermal Growth Factor

Addition/Correction pubs.acs.org/jmc

Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study Robert Heald,* Krista K. Bowman, Marian C. Bryan, Daniel Burdick, Bryan Chan, Emily Chan, Yuan Chen, Saundra Clausen, Belen Dominguez-Fernandez, Charles Eigenbrot, Richard Elliott, Emily J. Hanan, Philip Jackson, Jamie Knight, Hank La, Michael Lainchbury, Shiva Malek, Sam Mann, Mark Merchant, Kyle Mortara, Hans Purkey, Gabriele Schaefer, Stephen Schmidt, Eileen Seward, Steve Sideris, Lily Shao, Shumei Wang, Kuen Yeap, Ivana Yen, Christine Yu, and Timothy P. Heffron Journal of Medicinal Chemistry 2015, 58, 8877−8895. DOI: 10.1021/acs.jmedchem.5b01412 Page 8885. The stereochemistry of the 1-substituent (the trifluoropropanyl group) of compounds 41 and 42 in Table 8 was drawn incorrectly as (R) rather than (S). The structure is drawn correctly in all other places in the manuscript. The correct structure is shown below.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.6b00301 J. Med. Chem. XXXX, XXX, XXX−XXX